Adjuvant therapy of biliary tract cancers
Biliary tract cancers (BTCs) are rare and heterogeneous malignant tumours including cholangiocarcinoma and gallbladder cancer. They are very aggressive, often refractory to chemotherapy and associated with an overall poor prognosis. Surgical resection remains the only potentially curative treatment...
Main Authors: | Joanna Kefas, John Bridgewater, Arndt Vogel, Alexander Stein, John Primrose |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-03-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359231163785 |
Similar Items
-
Adjuvant treatment after resection of biliary-tract cancer: yes or no?
by: Eveline Boucher, et al.
Published: (2011-12-01) -
Targeted Therapy for Biliary Tract Cancer
by: Takuji Okusaka, et al.
Published: (2011-05-01) -
Changing Landscape of Systemic Therapy in Biliary Tract Cancer
by: Edward Woods, et al.
Published: (2022-04-01) -
Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer
by: Shunsuke Kato
Published: (2021-02-01) -
Real-world experience supporting the role of oncologic resection and adjuvant chemotherapy in biliary tract cancers
by: Melina Boutin, et al.
Published: (2024-04-01)